Hypersensitivity to the CGRP Inhibitor Monoclonal Antibodies Galcanezumab, Erenumab, and Fremanezumab With Tolerance to Eptinezumab.

Autor: Barroso B; Allergy Department, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain.; CIBER de Enfermedades Respiratorias (CIBERES), Madrid, Spain., Rodrigo-Muñoz JM; CIBER de Enfermedades Respiratorias (CIBERES), Madrid, Spain.; Immunology Department, IIS-Fundación Jiménez Díaz-UAM, Madrid, Spain., Gil-Martínez M; CIBER de Enfermedades Respiratorias (CIBERES), Madrid, Spain.; Immunology Department, IIS-Fundación Jiménez Díaz-UAM, Madrid, Spain., Del Pozo V; CIBER de Enfermedades Respiratorias (CIBERES), Madrid, Spain.; Immunology Department, IIS-Fundación Jiménez Díaz-UAM, Madrid, Spain., Rodríguez-Vico J; Headache Unit, Neurology Department, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain., Betancor D; Allergy Department, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain.; CIBER de Enfermedades Respiratorias (CIBERES), Madrid, Spain., Valverde-Monge M; Allergy Department, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain.; CIBER de Enfermedades Respiratorias (CIBERES), Madrid, Spain., Gómez-López A; Allergy Department, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain., Sastre J; Allergy Department, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain.; CIBER de Enfermedades Respiratorias (CIBERES), Madrid, Spain.
Jazyk: angličtina
Zdroj: Journal of investigational allergology & clinical immunology [J Investig Allergol Clin Immunol] 2024 Oct; Vol. 34 (5), pp. 348-349.
DOI: 10.18176/jiaci.1000
Databáze: MEDLINE